Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract C75: CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW610, NSC 721648) sensitivity in breast and colorectal cancer cells.

Chee-Onn Leong, Boon Shing Tan, Kai Hung Tiong, Ashwin Muruhadas, Nirmal Randhawa, Heng Lungh Choo, Malcolm FG Stevens, Tracey D. Bradshaw

Mol Cancer Ther (2011) 10 (11_Supplement): C75.

https://doi.org/10.1158/1535-7163.TARG-11-C75

Published: 12 November 2011

View article titled, Abstract C75: CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW610, NSC 721648) sensitivity in breast and colorectal cancer cells.

Journal Articles

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Boon Shing Tan, Kai Hung Tiong, Ashwin Muruhadas, Nirmal Randhawa, Heng Lungh Choo, Tracey D. Bradshaw, Malcolm F.G. Stevens, Chee-Onn Leong

Mol Cancer Ther (2011) 10 (10): 1982–1992.

https://doi.org/10.1158/1535-7163.MCT-11-0391

Published: 09 October 2011

View article titled, CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Includes: Supplementary data

Journal Articles

Abstract A143: Novel temozolomide analog may overcome MGMT and MMR

Jihong Zhang, Malcolm FG Stevens, Paul Kerschmeier, Marc Hummersone, Charles A. Laughton, Tracey D. Bradshaw

Mol Cancer Ther (2009) 8 (12_Supplement): A143.

https://doi.org/10.1158/1535-7163.TARG-09-A143

Published: 10 December 2009

View article titled, Abstract A143: Novel temozolomide analog may overcome MGMT and MMR

Journal Articles

Abstract B59: Preliminary clinical experiences of Phortress: Putative role for c‐MET inhibition in antitumor activity

Tracey D. Bradshaw, Malcolm F.G. Stevens, Hilary Calvert, E. Ruth Plummer

Mol Cancer Ther (2009) 8 (12_Supplement): B59.

https://doi.org/10.1158/1535-7163.TARG-09-B59

Published: 10 December 2009

View article titled, Abstract B59: Preliminary clinical experiences of Phortress: Putative role for c‐MET inhibition in antitumor activity

Journal Articles

Abstract B164: Role of endoplasmic reticulum stress in mechanism of action of antitumor quinols

Charles S. Matthews, Andrew J. McCarroll, Malcolm FG Stevens, Anne Monks, Tracey D. Bradshaw

Mol Cancer Ther (2009) 8 (12_Supplement): B164.

https://doi.org/10.1158/1535-7163.TARG-09-B164

Published: 10 December 2009

View article titled, Abstract B164: Role of endoplasmic reticulum stress in mechanism of action of antitumor quinols

Journal Articles

In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles

Chee Onn Leong, Marie Suggitt, David J. Swaine, Michael C. Bibby, Malcolm F.G. Stevens, Tracey D. Bradshaw

Mol Cancer Ther (2004) 3 (12): 1565–1575.

https://doi.org/10.1158/1535-7163.1565.3.12

Published: 04 January 2005

View article titled, In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles

Journal Articles

Preclinical Evaluation of Amino Acid Prodrugs of Novel Antitumor 2-(4-Amino-3-Methylphenyl)Benzothiazoles

Tracey D. Bradshaw, Michael C. Bibby, John A. Double, Iduna Fichtner, Patricia A. Cooper, Michael C. Alley, Susan Donohue, Sherman F. Stinson, Joseph E. Tomaszewjski, Edward A. Sausville, Malcolm F. G. Stevens

Mol Cancer Ther (2002) 1 (4): 239–246.

Published: 01 February 2002

View article titled, Preclinical Evaluation of Amino Acid Prodrugs of Novel Antitumor 2-(4-Amino-3-Methylphenyl)Benzothiazoles

NARROW

Abstract C75: CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW610, NSC 721648) sensitivity in breast and colorectal cancer cells.

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Abstract A143: Novel temozolomide analog may overcome MGMT and MMR

Abstract B59: Preliminary clinical experiences of Phortress: Putative role for c‐MET inhibition in antitumor activity

Abstract B164: Role of endoplasmic reticulum stress in mechanism of action of antitumor quinols

In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles

Preclinical Evaluation of Amino Acid Prodrugs of Novel Antitumor 2-(4-Amino-3-Methylphenyl)Benzothiazoles

Email alerts

AACR Journals

Abstract C75: CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW610, NSC 721648) sensitivity in breast and colorectal cancer cells.

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Abstract A143: Novel temozolomide analog may overcome MGMT and MMR

Abstract B59: Preliminary clinical experiences of Phortress: Putative role for c‐MET inhibition in antitumor activity

Abstract B164: Role of endoplasmic reticulum stress in mechanism of action of antitumor quinols

In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles

Preclinical Evaluation of Amino Acid Prodrugs of Novel Antitumor 2-(4-Amino-3-Methylphenyl)Benzothiazoles

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only